MAXWELL FINLAND, M.D., F.A.C.P.; OSLER L. PETERSON, M.D.; ROBERT A. GOODWIN JR., M.D.
Evidence for the effectiveness of sulfadiazine in many of the common bacterial infections has now been obtained in several large clinics by a number of observers, all of whom have attested to the relatively low toxicity of this drug.1, 2, 3, 4, 5 Since the time of our earlier publication on this subject,2 the use of sulfadiazine at the Boston City Hospital was limited largely to those groups of cases in which additional data seemed desirable. In this paper we wish to summarize the past year's experience with the clinical use of sulfadiazine at this hospital and, in so doing,
MAXWELL FINLAND, OSLER L. PETERSON, ROBERT A. GOODWIN. SULFADIAZINE; FURTHER CLINICAL STUDIES OF ITS EFFICACY AND TOXIC EFFECTS IN 460 PATIENTS(SULFADIAZINE; FURTHER CLINICAL STUDIES OF ITS EFFICACY AND TOXIC EFFECTS IN 460 PATIENTS*). Ann Intern Med. 1942;17:920–934. doi: 10.7326/0003-4819-17-6-920
Download citation file:
Published: Ann Intern Med. 1942;17(6):920-934.
Results provided by:
Copyright © 2017 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use